COMMUNIQUÉS West-GlobeNewswire

Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

14/03/2018 - 21:01

- New positive clinical and translational data for both lead agents - Strong balance sheet with 2017 year-end cash and equivalents of $144.2 Million - Conference call at 1:30 pm Pacific today SEATTLE and SOUTH SAN [...]

La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock

14/03/2018 - 21:01

SAN DIEGO, March 14, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) (La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients [...]

Arbutus Announces Corporate Update and Year-End 2017 Financial Results

14/03/2018 - 21:00

ARB-1467 Phase II Combination Study Beginning in 1Q18 Two New Drug Candidates Planned to Enter Clinical Development in 2H18 Over $200M in Cash Available to Fund Development of HBV Assets Company to Host a Corporate [...]

Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update

14/03/2018 - 21:00

Planning to Initiate HOPE-2 Clinical Trial To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology [...]

Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call

14/03/2018 - 19:30

PARSIPPANY, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (the “Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular [...]

EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018

14/03/2018 - 19:14

LYON, France, March 14, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the year ended December 31, 2017, after the close of [...]

Virbac : operating profit from ordinary activities 2017 comparable to 2016

14/03/2018 - 17:46

Virbac: operating profit from ordinary activities 2017 comparable to 2016 Public release dated March 14, 2018 CONSOLIDATED DATA AS OF DECEMBER 31 st in € million 2017 2016 % change 2017/2016 Revenue from ordinary [...]

Virbac : résultat opérationnel courant 2017 comparable à 2016

14/03/2018 - 17:46

Virbac: résultat opérationnel courant 2017 comparable à 2016 Communiqué diffusé le 14 mars 2018 CHIFFRES CONSOLIDÉS AU 31 DÉCEMBRE en millions € 2017 2016 Évolution 2017/2016 Chiffre d'affaires 861,9 871,8 -1,1% [...]

BriaCell Appoints Top Social Media Marketing Analyst

14/03/2018 - 17:21

BERKELEY, Calif. and VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

Cognition Therapeutics Presenting Evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined AAT-AD/PD Focus Meeting

14/03/2018 - 15:33

Pittsburgh, March 14, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and [...]

Tabula Rasa HealthCare to Participate in the Oppenheimer 28th Annual Healthcare Conference

14/03/2018 - 15:06

MOORESTOWN, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

14/03/2018 - 14:31

FIT Biotech Oy Company release March 14, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Amedisys to Present at the 28th Annual Oppenheimer Healthcare Conference

14/03/2018 - 14:00

BATON ROUGE, La., March 14, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive [...]

Zynerba Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference

14/03/2018 - 14:00

DEVON, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]

BLVD Centers Launches Weedaide™ Website in Advance of Product Launch

14/03/2018 - 14:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- BLVD Centers Corporation (“ BLVD ” or the “ Company ”) (TSXV:CXV), a [...]

Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing

14/03/2018 - 14:00

LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical , (OTC:CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing. Bringing more than 35 years [...]

PRA Health Sciences Receives CRO Leadership Award

14/03/2018 - 14:00

RALEIGH, N.C., March 14, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce it has won a 2018 CRO Phase IV Leadership Award (Overall, Big Pharma). For the 2018 CRO Leadership [...]

Immunicum AB: The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board

14/03/2018 - 13:44

Press Release 14 March 2018 The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board The Nomination Committee of Immunicum (publ; IMMU.ST) has informed the Company that they [...]

Kalytera Announces Grant of Stock Options to Chief Scientific Officer and Chief Medical Officer

14/03/2018 - 13:30

SAN FRANCISCO and TEL AVIV, Israel, March 14, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that it has granted stock options on [...]